However, the administration of tectoridin significantly increased the expression levels of Nrf2 and HO-1, suggesting its potential therapeutic efficacy in ischemic stroke through modulation of the Nrf2/HO-1 pathway. The gene discussed is HMOX1; the disease is ischemic stroke.